Vonoref-20 Tablets | Biophar Group

Biophar GroupBiophar Group
3 min read

Vonoref-20 Tablets (Vonoprazan 20 mg) – A New Era in Acid Control

Products Details

Brand Name: Vonoref-20 Tablets
Composition: Vonoprazan Tablets 20 mg
Colour: Ferric Oxide USP-NE Red and Titanium Dioxide IP
MRP: ₹220/- per strip
Packaging: 10×10 Aluminium Foil Strip
Category: Gastroenterology
Manufactured by: Hetero Labs Limited
Marketed by: Biophar Group
Storage: Store below 30°C

Why Vonoref is the Right Choice Now

Vonoref-20, powered by the advanced molecule Vonoprazan, represents a breakthrough in the management of acid-related disorders like GERD, chronic acidity, reflux, and peptic ulcers. Best pharma brand vonoref-20 It offers superior relief, especially for patients who do not respond well to conventional treatments like Pantoprazole DSR or Rabeprazole DSR capsules. While many patients continue to suffer despite using standard PPIs, Vonoprazan—formulated in Vonoref—has shown quicker, deeper, and more sustained acid suppression, often without the side effects associated with older therapies.


The Science and Legacy Behind Vonoprazan

Vonoprazan was originally developed and patented by Takeda Pharmaceuticals, a globally recognized leader in gastroenterology research. Acid relief solution of Vonoref-20 Tablets. The molecule demonstrated powerful acid-blocking potential, positioning it as a next-generation alternative to proton pump inhibitors (PPIs).

In India, Takeda granted manufacturing rights to Hetero Drugs, one of the most respected names in pharmaceutical manufacturing. Today, Hetero supplies Vonoprazan to only the top 25 pharma companies—including Biophar Group the marketer of Vonoref-20 Tablets.


Why Doctors Are Taking Notice

Some doctors have already heard about Vonoprazan through CME programs and doctor meetings, while others are just beginning to explore its potential. This is the perfect time to introduce Vonoref-20 Tablets. to your doctor network—before the molecule becomes widely available and competitive.

Once introduced, doctors quickly recognize the clinical advantages of Vonoref-20 and begin switching eligible patients, particularly those:

  • Not getting relief from pantoprazole or rabeprazole-based combinations

  • Experiencing relapse or incomplete healing

  • Requiring long-term acid suppression without risk of side effects


The Vonoref-20 Advantage: Same Product, Same Facility, Superior Positioning

Here’s what makes Vonoref-20 truly unique:

  • Manufactured at the same facility by Hetero Drugs as all top brands using Vonoprazan

  • Identical formulation, same quality, same purity, only the brand name changes

  • No internal competition: All companies source the API and formulation from the same place

  • Biophar’s strong brand presence and ethical image adds credibility to the product

Doctors will respect your product—because it's backed by a molecule they trust and a company with high standards.


Build Your Image. Grow Your Business.

When you promote Vonoref-20, you align yourself with premium quality, international research, and scientific innovation. Doctors will regard you as a pharma partner who brings cutting-edge, clinically effective solutions—not just commodity products. Vonoref-20 Tablets franchise in india

This positions you to:


This Is the Moment to Take Action

Vonoprazan is not yet saturated in the Indian market. This is the right time to introduce Vonoref-20 in your area, gain the first-mover advantage, and build a stronghold in the gastro segment with zero competition and maximum returns.

With Biophar Group backing you and Hetero Drugs' top-tier manufacturing behind the product, you’re set to achieve big success.


Contact Biophar Today

📞 Call/WhatsApp: +91-9888871967
📧 Email: biophar.purchase@gmail.com
🌐 Website: www.biophargroup.com

Vonoref-20 — Trusted molecule. Trusted manufacturer. Trusted brand.

Now is the time to grow your image and income with Biophar Group launch a unick brand of Vonoref-20.

https://www.biophargroup.com/

0
Subscribe to my newsletter

Read articles from Biophar Group directly inside your inbox. Subscribe to the newsletter, and don't miss out.

Written by

Biophar Group
Biophar Group